Pharmacogenetic testing in the Veterans Health Administration (VHA): policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee
Jason L. Vassy(Boston Medical Center), Steven A. Schichman(Central Arkansas Veterans Healthcare System), Victoria M. Pratt(Indiana University – Purdue University Indianapolis), Annjanette Stone(Central Arkansas Veterans Healthcare System), Margaret Mendes(VA San Diego Healthcare System), Ronald M. Przygodzki(VA Office of Research and Development), Jessica Wang‐Rodriguez(University of California San Diego), Maren T. Scheuner(Unknown), Laurence J. Meyer(University of Utah), John T. Callaghan(Richard L. Roudebush VA Medical Center)
Cited by 18
Related Papers
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
|Nature Genetics|1994|850
Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis.
|Journal of Clinical Investigation|1990|269
Genotyping Array Design and Data Quality Control in the Million Veteran Program
|The American Journal of Human Genetics|2020|218